Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 1 | 0 | €1.63 | €4.39 | 169.240% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| X4 Pharmaceuticals, Inc. | 5 | 0 | 2 | 0 | €1.09 | €2.76 | 153.003% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €336.70 | €369.72 | 9.808% |
| WAVE Life Sciences Ltd | 8 | 0 | 1 | 0 | €4.44 | €9.10 | 104.973% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.79 | - | - |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €345.00 | - | - |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.81 | - | - |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €41.80 | - | - |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.75 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.32 | €5.00 | 15.741% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.51 | €7.00 | 99.544% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €95.50 | €108.77 | 13.894% |
| Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €462.95 | €543.72 | 17.447% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| UCB S.A. | 2 | 0 | 0 | 0 | €124.95 | - | - |